Yes. Gender selection is now a real possibility thanks to a technology called PGD (pre-implantation genetic screening) and PGD (pre-implantation genetic diagnosis).
PGS/PGD can help patients not only select the gender of their child but also determine if an embryo contains a normal number of chromosomes. It can also identify particular genetic diseases that a patient may be carrying.
PGS/PGD allows patients to choose their baby’s sex by identifying male and female embryos conceived in a laboratory, prior to transfer to the woman’s uterus. PGS requires an IVF be performed. After fertilization, specialists examine the embryo for its sex chromosomes (XX for a female or XY for male), and a fertility Doctor tranfers an embryo of the selected sex into the woman’s uterus.
PGS/PGD has a 99 % accuracy in predicting an embryo’s gender, this technology gives patients the best odds in determining their baby’s gender.
PGD can detect abnormalities of chromosome numbers, such as Down syndrome. It can also identify other serious single-gene disorders such as cystic fibrosis and sickle-cell anemia prior to embryo transfer.
PGD/PGS genetic testing may be recommended by a Fertility Doctor when there is a possibility, indicated by your medical history or advanced maternal age, that your embryos could be affected by a genetic disease and hence passing on an inherited genetic disease to your children. These genetic conditions can also interfere with embryo implantation decreasing your chances of a successful pregnancy.